Dynasil Corporation of America (NASDAQ:DYSL) Files An 8-K Regulation FD Disclosure

Dynasil Corporation of America (NASDAQ:DYSL) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure

 

to Regulation FD, Dynasil Corporation of America (“Dynasil” or the “Company”) hereby furnishes slides that the Company will present to stockholders and investors on or after February 23, 2017. The slides are attached hereto as Exhibit 99.1. These slides will be available on Dynasil’s website at www.dynasil.com. The information furnished by the Company to this item, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liability of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

 

99.1 Slides presented by Dynasil Corporation of America to stockholders on or after February 23, 2017.


About Dynasil Corporation of America (NASDAQ:DYSL)

Dynasil Corporation of America is engaged in the development, marketing and manufacturing of detection, sensing and analysis technology and optical components, as well as contract research. The Company operates through three segments, including Contract Research, Optics and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (RMD) business unit. The Optics segment operates through four business units: Dynasil Fused Silica, Optometrics Corporation, Hilger Crystals, Ltd. and Evaporated Metal Films Corporation, which manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Biomedical segment consists of a business unit, Dynasil Biomedical Corporation, a medical technology incubator, which owns rights to certain early-stage medical technologies.

Dynasil Corporation of America (NASDAQ:DYSL) Recent Trading Information

Dynasil Corporation of America (NASDAQ:DYSL) closed its last trading session down -0.05 at 1.18 with 156,302 shares trading hands.

An ad to help with our costs